|
US 11,939,400 B2 |
|
| Immunotherapy against several tumors including lung cancer |
| Toni Weinschenk, Tuebingen (DE); Steffen Walter, Houston, TX (US); Jens Fritsche, Tuebingen (DE); Colette Song, Tuebingen (DE); and Harpreet Singh, Tuebingen (DE) |
| Assigned to Immatics Biotechnologies GmbH, (DE) |
| Filed by Immatics Biotechnologies GmbH, Tuebingen (DE) |
| Filed on Mar. 10, 2022, as Appl. No. 17/691,576. |
| Application 17/691,576 is a continuation of application No. 17/525,023, filed on Nov. 12, 2021. |
| Application 17/525,023 is a continuation of application No. 17/238,932, filed on Apr. 23, 2021. |
| Application 17/238,932 is a continuation of application No. 16/599,198, filed on Oct. 11, 2019, granted, now 11,161,877, issued on Nov. 2, 2021. |
| Application 16/599,198 is a continuation of application No. 16/444,693, filed on Jun. 18, 2019, granted, now 10,479,818, issued on Nov. 19, 2019. |
| Application 16/444,693 is a continuation of application No. 15/639,165, filed on Jun. 30, 2017, abandoned. |
| Application 15/639,165 is a continuation of application No. 14/908,078, abandoned, previously published as PCT/EP2014/066755, filed on Aug. 4, 2014. |
| Claims priority of provisional application 61/862,213, filed on Aug. 5, 2013. |
| Claims priority of application No. 1313987 (GB), filed on Aug. 5, 2013; and application No. 1403297 (GB), filed on Feb. 25, 2014. |
| Prior Publication US 2022/0194984 A1, Jun. 23, 2022 |
| This patent is subject to a terminal disclaimer. |
| Int. Cl. C07K 7/06 (2006.01); A61K 38/17 (2006.01); A61K 39/00 (2006.01); A61K 45/06 (2006.01); C07K 7/08 (2006.01); C07K 14/725 (2006.01); C12N 5/0783 (2010.01); C12N 9/64 (2006.01) |